Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1975 4
1976 5
1978 1
1979 4
1980 3
1981 5
1982 5
1983 4
1984 2
1985 9
1986 6
1987 5
1988 5
1989 15
1990 29
1991 26
1992 16
1993 31
1994 30
1995 47
1996 38
1997 50
1998 49
1999 67
2000 54
2001 78
2002 122
2003 151
2004 154
2005 219
2006 221
2007 223
2008 240
2009 279
2010 315
2011 360
2012 341
2013 412
2014 403
2015 419
2016 417
2017 410
2018 412
2019 416
2020 394
2021 406
2022 331
2023 308
2024 111

Text availability

Article attribute

Article type

Publication date

Search Results

6,723 results

Results by year

Filters applied: . Clear all
Page 1
Overview of treatment approaches to osteoporosis.
Langdahl BL. Langdahl BL. Br J Pharmacol. 2021 May;178(9):1891-1906. doi: 10.1111/bph.15024. Epub 2020 Mar 20. Br J Pharmacol. 2021. PMID: 32060897 Free article. Review.
Anti-resorptive therapies, including bisphosphonates and denosumab, increase bone mineral density (BMD) and reduce the risk of fractures by 20-70%. Bone-forming or dual-action treatments stimulate bone formation and increase BMD more than the an …
Anti-resorptive therapies, including bisphosphonates and denosumab, increase bone mineral density (BMD) and reduce the …
UBAP2 plays a role in bone homeostasis through the regulation of osteoblastogenesis and osteoclastogenesis.
Kim J, Kim BY, Lee JS, Jeong YM, Cho HJ, Park E, Kim D, Kim SS, Kim BT, Choi YJ, Won YY, Jin HS, Chung YS, Jeong SY. Kim J, et al. Nat Commun. 2023 Jun 20;14(1):3668. doi: 10.1038/s41467-023-39448-8. Nat Commun. 2023. PMID: 37339951 Free PMC article.
Osteoporosis is a condition characterized by decreased bone mineral density (BMD) and reduced bone strength, leading to an increased risk of fractures. ...UBAP2 protein level is correlated with the blood plasma level of the representative osteoporosis …
Osteoporosis is a condition characterized by decreased bone mineral density (BMD) and reduced bone strength, lea …
Low bone mineral density is a common feature of Zellweger spectrum disorders.
Rush ET, Goodwin JL, Braverman NE, Rizzo WB. Rush ET, et al. Mol Genet Metab. 2016 Jan;117(1):33-7. doi: 10.1016/j.ymgme.2015.11.009. Epub 2015 Nov 24. Mol Genet Metab. 2016. PMID: 26643206
We investigated 13 ZSD patients who had strikingly abnormal bone mineral density for age. DXA scans showed mean lumbar and femoral neck Z-scores of -3.2. ...Cyclic bisphosphonate therapy in one ZSD patient was successfully used to increase in bone m …
We investigated 13 ZSD patients who had strikingly abnormal bone mineral density for age. DXA scans showed mean lumbar …
Exercise and bone mineral density.
Chilibeck PD, Sale DG, Webber CE. Chilibeck PD, et al. Sports Med. 1995 Feb;19(2):103-22. doi: 10.2165/00007256-199519020-00003. Sports Med. 1995. PMID: 7747001 Review.
Studies have demonstrated increases in bone formation in animals and increases in bone mineral density in humans. ...Cross-sectional studies show that athletes, especially those who are strength-trained, have greater bone mineral densitie …
Studies have demonstrated increases in bone formation in animals and increases in bone mineral density in humans …
Bone mineral density in children with acute lymphoblastic leukemia.
Inaba H, Cao X, Han AQ, Panetta JC, Ness KK, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Pui CH, Relling MV, Kaste SC. Inaba H, et al. Cancer. 2018 Mar 1;124(5):1025-1035. doi: 10.1002/cncr.31184. Epub 2017 Dec 19. Cancer. 2018. PMID: 29266176 Free PMC article.
BACKGROUND: Children with acute lymphoblastic leukemia (ALL) can develop reduced bone mineral density (BMD). However, data from patients who received treatment on a frontline regimen without cranial irradiation are limited, and no genome-wide analysis has bee …
BACKGROUND: Children with acute lymphoblastic leukemia (ALL) can develop reduced bone mineral density (BMD). However, d …
Anaphase-Promoting Complex Subunit 1 Associates with Bone Mineral Density in Human Osteoporotic Bone.
Malavašič P, Polajžer S, Lovšin N. Malavašič P, et al. Int J Mol Sci. 2023 Aug 17;24(16):12895. doi: 10.3390/ijms241612895. Int J Mol Sci. 2023. PMID: 37629076 Free PMC article.
Genome-wide association studies (GWAS) are one of the most common approaches to identify genetic loci that are associated with bone mineral density (BMD). Such novel genetic loci represent new potential targets for the prevention and treatment of fragility fr …
Genome-wide association studies (GWAS) are one of the most common approaches to identify genetic loci that are associated with bone …
Romosozumab for the treatment of osteoporosis.
Bandeira L, Lewiecki EM, Bilezikian JP. Bandeira L, et al. Expert Opin Biol Ther. 2017 Feb;17(2):255-263. doi: 10.1080/14712598.2017.1280455. Expert Opin Biol Ther. 2017. PMID: 28064540 Review.
Sclerostin, a glycoprotein produced primarily by osteocytes, blocks the canonical Wnt signaling bone formation pathway. Romosozumab is a humanized monoclonal antibody to sclerostin that binds to sclerostin, permitting the engagement of Wnt ligands with their co-receptors, …
Sclerostin, a glycoprotein produced primarily by osteocytes, blocks the canonical Wnt signaling bone formation pathway. Romosozumab i …
Changes to volumetric bone mineral density and bone strength after stroke: a prospective study.
Borschmann K, Pang MY, Iuliano S, Churilov L, Brodtmann A, Ekinci EI, Bernhardt J. Borschmann K, et al. Int J Stroke. 2015 Apr;10(3):396-9. doi: 10.1111/ijs.12228. Epub 2013 Dec 23. Int J Stroke. 2015. PMID: 24373530
SECONDARY OUTCOMES: The secondary outcomes are cortical and trabecular volumetric bone mineral density, cortical thickness, and total and cross-sectional areas of distal tibiae and radii of paretic and nonparetic limbs. Also included are total body and region …
SECONDARY OUTCOMES: The secondary outcomes are cortical and trabecular volumetric bone mineral density, cortical thickn …
One-year adolescent bone mineral density and bone formation marker changes through the use or lack of use of combined hormonal contraceptives.
Rizzo ADCB, Goldberg TBL, Biason TP, Kurokawa CS, Silva CCD, Corrente JE, Nunes HRC. Rizzo ADCB, et al. J Pediatr (Rio J). 2019 Sep-Oct;95(5):567-574. doi: 10.1016/j.jped.2018.05.011. Epub 2018 Jun 28. J Pediatr (Rio J). 2019. PMID: 29959901 Free article.
Adolescents underwent anthropometric assessment and densitometry (dual-energy X-ray). Bone age and bone formation markers (osteocalcin and bone alkaline phosphatase) were evaluated. ...Linear regression analysis showed an increase in bone mineral …
Adolescents underwent anthropometric assessment and densitometry (dual-energy X-ray). Bone age and bone formation markers (ost …
Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.
Söderpalm AC, Magnusson P, Ahlander AC, Karlsson J, Kroksmark AK, Tulinius M, Swolin-Eide D. Söderpalm AC, et al. Neuromuscul Disord. 2007 Dec;17(11-12):919-28. doi: 10.1016/j.nmd.2007.05.008. Epub 2007 Jul 12. Neuromuscul Disord. 2007. PMID: 17627820
Our study demonstrated lower bone mineral density in the DMD group for total body, spine, hip, heel and forearm measurements. ...Interventions that increase bone formation should be considered, as DMD patients have reduced bone turnover in addit …
Our study demonstrated lower bone mineral density in the DMD group for total body, spine, hip, heel and forearm measure …
6,723 results